The Leadership Team at Synklino oversees the strategic direction and operational management of the company, ensuring the successful development and commercialization of their CMV-specific immunotoxin. This team collaborates closely to make high-level decisions, secure funding, manage resources, and guide clinical and regulatory strategies to eradicate cytomegalovirus infection.
View all